Inhaled steroids do not decrease bone mineral density but increase risk of fractures: data from the GIUMO Study Group.

[1]  H. Nelson.  Combination therapy of long-acting β agonists and inhaled corticosteroids in the management of chronic asthma , 2005, Current allergy and asthma reports.

[2]  Ashokakumar M. Patel,et al.  Long‐Term Fracture Risk Among Children With Asthma: A Population‐Based Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  M. Curiel,et al.  Study of bone mineral density in lumbar spine and femoral neck in a Spanish population , 2005, Osteoporosis International.

[4]  M. V. Van Kerkhove,et al.  Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  S. Suissa,et al.  Inhaled and nasal corticosteroid use and the risk of fracture. , 2004, American journal of respiratory and critical care medicine.

[6]  L. Boulet,et al.  Adult Asthma Consensus Guidelines update 2003. , 2004, Canadian respiratory journal.

[7]  Ashokakumar M. Patel,et al.  Long-term fracture risk following adult-onset asthma: a population-based study , 2004, Osteoporosis International.

[8]  S. Szefler,et al.  Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. , 2003, Chest.

[9]  E. Schoon,et al.  Osteoporosis in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[10]  D. Sin,et al.  The risk of osteoporosis in Caucasian men and women with obstructive airways disease. , 2003, The American journal of medicine.

[11]  T. Ishizuka,et al.  Effects of fluticasone propionate on bone mineral density in patients with persistent bronchial asthma. , 2002, Internal medicine.

[12]  O. Johnell,et al.  Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler® , 2002, European Respiratory Journal.

[13]  G. Fitzmaurice,et al.  Effects of inhaled glucocorticoids on bone density in premenopausal women , 2002 .

[14]  N. Guañabens,et al.  Quantitative Ultrasound Calcaneus Measurements: Normative Data and Precision in the Spanish Population , 2002, Osteoporosis International.

[15]  C. Cooper,et al.  Epidemiology of fractures in England and Wales. , 2001, Bone.

[16]  L. Çöplü,et al.  Effect of the long‐term use of inhaled corticosteroids on bone mineral density in asthmatic women , 2001, Respirology.

[17]  Y. Nagasaka,et al.  Inhaled Corticosteroids Reduce Bone Mineral Density in Early Postmenopausal but Not Premenopausal Asthmatic Women , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  A. Kamanlı,et al.  Effects of long-term inhaled steroid use on bone mineral density in asthma patients. , 2001, Journal of investigational allergology & clinical immunology.

[19]  M. Metintaş,et al.  Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma. , 2001, Allergologia et immunopathologia.

[20]  P. Rüegsegger,et al.  Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects , 2000, Thorax.

[21]  P. Sambrook.  Inhaled corticosteroids, bone density, and risk of fracture , 2000, The Lancet.

[22]  R F Heller,et al.  Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: A literature review , 1999, Respirology.

[23]  B. Lipworth.  Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. , 1999, Archives of internal medicine.

[24]  J. Hopper,et al.  Bone Mineral Density and Bone Turnover in Asthmatics Treated with Long‐Term Inhaled or Oral Glucocorticoids , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  C. Picado,et al.  Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. , 1997, The European respiratory journal.

[26]  S. Cummings,et al.  Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. , 1995, The American journal of medicine.

[27]  J. G. Douglas,et al.  Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. , 1992, Thorax.

[28]  P. Tothill,et al.  Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. , 1986, British medical journal.